0
New
New
2023
Hysterectomy Device Market

Hysterectomy Device Market

by Disease type (Uterine Cancer, Fibroids, Chronic pelvic pain, Others), by Surgical approach (Vaginal hysterectomy, Laparoscopic hysterectomy, Robotic assisted laparoscopic hysterectomy, Abdominal hysterectomy), by End User (Hospitals, Ambulatory Surgical Centers, Others): Global Opportunity Analysis and Industry Forecast, 2022-2031

Report Code: A13324
Aug 2023 | Pages: 389
Tables: 129
Charts: 64
  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.

 

Hysterectomy Device Market Research, 2031

The global hysterectomy device market size was valued at $328.1 million in 2021 and is projected to reach $566.5 million by 2031, growing at a CAGR of 5.6% from 2022 to 2031. Hysterectomy devices are medical devices used in the surgical removal of the uterus. Hysterectomies are a common gynecological procedure, and the devices used in these procedures can vary depending on the type of surgery performed. This can be done for a variety of reasons, such as to treat gynecological conditions like uterine fibroids, endometriosis, and abnormal uterine bleeding, or to treat certain types of cancer. Hysterectomies can be performed through a variety of surgical techniques, including open surgery, laparoscopic surgery, and robotic-assisted surgery. The choice of surgical technique depends on a number of factors, including the patient's medical history, the reason for the hysterectomy, and the surgeon's preference. 

The hysterectomy device market was negatively impacted during the lockdown period owing to a decline in demand for hysterotomy devices due to delayed planned surgeries such as hysterectomies. However, the market is anticipated to witness recovery during the forecast period, and show stable growth for hysterotomy devices.

Hysterectomy Device Market

Market Dynamics

The hysterectomy device market trends which drive the growth of the market include the increased prevalence of uterine cancer, which is frequently treated by hysterectomy, which is anticipated to increase demand for these devices. Moreover, the popularity of minimally invasive hysterectomy devices including laparoscopic devices and robotic-assisted surgical systems has increased due to the shift towards minimally invasive surgery which further fuels the growth of the market. To address the rising demand for minimally invasive procedures, medical device manufacturers are investing in the creation of new and improved equipment. Minimally invasive procedures are becoming more acceptable since they are linked to quicker recovery periods, fewer pain and scarring side effects, and shorter hospital stays. Thus, increasing demand for minimally invasive procedures drives the hysterectomy device market growth. 

In addition, the rising emphasis on recognizing and meeting specific health requirements and concerns of women is referred to as the growth in awareness of women's health. There has been a considerable trend in the medical community recently toward acknowledging and addressing gender-specific health issues. Thus, an increase in awareness about women’s health propels the hysterectomy device industry growth. 

Furthermore, the growing focus on women's health issues in the media and the medical community is expected to drive greater awareness of the available treatment options, including hysterectomy, and further fuel demand for these devices. Women's health awareness campaigns may contribute to the growth of the hysterectomy market, it is important to prioritize individual medical needs and ensure that the decision to undergo this procedure is made in consultation with a healthcare provider. The increasing emphasis on women's health and the availability of more advanced and less invasive treatment options are expected to drive growth in the hysterectomy device industry during the forecast period.

In addition, the market for hysterectomy devices has grown significantly as a result of technological improvements. Due to the development of new and improved surgical techniques and tools, hysterectomy is now a safer, less invasive, and more practical treatment for female patients. Open surgery was used in traditional hysterectomy treatments, which required a significant incision and a lengthy healing period. Thus, the development of technology fuels the market. Additionally, owing to advancements in technology, the market for hysterectomy devices market growth is anticipated during the forecast period. 

Moreover, the rising prevalence of uterine cancer drives market growth. In addition to uterine cancer, hysterectomy is also used for the treatment of other gynecologic conditions such as uterine fibroids, endometriosis, and abnormal uterine bleeding. These conditions also contribute to the demand for hysterectomy procedures. Uterine cancer is the most common gynecologic cancer in women, and in some cases, a hysterectomy is the primary treatment option. For an instance, according to the National Cancer Institute, the rate of new cases of uterine cancer was 27.8 per 100,000 women per year. The death rate was 5.1 per 100,000 women per year. Approximately 3.1% of women will be diagnosed with uterine cancer at some point during their lifetime. Thus, the high prevalence of uterine cancer drives market growth. 

However, a hysterectomy is a major surgical procedure that requires specialized equipment and skilled healthcare professionals. The high cost of treatment and availability of alternative treatments are expected to restrain the growth of the hysterectomy device market. The total cost of a hysterectomy can include the cost of the surgery, anesthesia, hospital stay, and follow-up care, among other factors.  

Hysterectomy is a common and effective treatment for certain gynecologic conditions. It is a major surgical procedure that carries risks and can have long-term consequences, such as infertility and menopausal symptoms. Thus, the availability of alternative treatments can potentially restrain the growth of the hysterectomy device market as patients may adopt other treatments such as hormonal therapy or uterine artery embolization, which are less invasive and may offer faster recovery times.

On the other hand, the increasing demand for minimally invasive procedures and robotic-assisted surgeries is anticipated as the hysterectomy devices market opportunity during the forecast period. Minimally invasive procedures such as laparoscopic or robotic-assisted laparoscopic surgeries have gained popularity due to their potential benefits, including shorter hospital stays, lesser blood loss, and faster recovery times compared to traditional open surgery. The rise in demand for minimally invasive procedures is seen as an opportunity for the growth of the hysterectomy device market, as manufacturers develop new devices to meet the needs of these procedures. 

The outbreak of COVID-19 has disrupted workflows in the healthcare sector around the world. Many hospitals and healthcare facilities canceled or postponed elective procedures, including hysterectomies, to conserve resources and reduce the risk of COVID-19 transmission. This may have resulted in decreased demand for hysterectomy devices during the pandemic. The disease has forced a number of industries to shut their doors temporarily, including several sub-domains of health care. The COVID-19 pandemic has had a considerable impact on the market for hysterectomy devices. The pandemic has disrupted supply chains, which has resulted in a shortage of medical supplies, particularly hysterectomies. This has made it difficult for medical staff to obtain the equipment they need to carry out surgery, resulting in cancellations or delays. 

Segmental Overview 

The hysterectomy device market size is segmented into disease type, surgical approach, end user, and region. By product type, the market is categorized into uterine cancer, fibroids, chronic pelvic pain, and others. On the basis of surgical approach, the market is segregated into vaginal hysterectomy, laparoscopic hysterectomy, robotic-assisted laparoscopic hysterectomy, and abdominal hysterectomy. On the basis of end user, the market is categorized into hospitals, ambulatory surgical center, and others. Region-wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. 

By Disease Type

The hysterectomy device market share is segmented into uterine cancer, fibroids, chronic pelvic pain, and others (uterine prolapse, endometriosis, adenomyosis) The uterine cancer segment dominated the global market in 2021 and is expected to remain dominant throughout the forecast period, owing to a high prevalence of uterine cancer. 

Hysterectomy Device Market
By Disease Type

Your browser does not support the canvas element.

Chronic pelvic pain segment dominated the market in 2021 and fibroids segement is expected to be lucrative during the forecast period.

Get more information on this report : Request Sample Pages

 By Surgical Approach

The hysterectomy device market analysis is segmented into vaginal hysterectomy, laparoscopic hysterectomy, robotic-assisted laparoscopic hysterectomy, and abdominal hysterectomy. The laparoscopic hysterectomy segment dominated the global market in 2021, owing to patients typically experience less pain, less scarring, and a shorter recovery time compared to traditional open surgery. And robotic-assisted laparoscopic hysterectomy is expected to witness growth owing to its precision, allowing for more targeted tissue dissection and reduced blood loss during surgery. 

Hysterectomy Device Market
By Surgical Approach

Your browser does not support the canvas element.

Abdominal hysterectomy segment dominated the market in 2021 and robotic assisted laparoscopic hysterectomy segement is expected to be lucrative during the forecast period.

Get more information on this report : Request Sample Pages

By End User

The hysterectomy device market is classified into hospitals, ambulatory surgical centers, and others. The hospitals' segment held the largest market share in 2021 and is expected to remain dominant, owing to it offering diagnosis for the detection of diseases, preoperative care, and postoperative care, making it a one-stop-shop for patients undergoing hysterectomy procedures. The ambulatory surgical center centers segment is projected to register the highest CAGR owing to it being increasingly popular in recent years due to the focus on same-day surgeries and minimally invasive procedures.   

Hysterectomy Device Market
By End User

Your browser does not support the canvas element.

Hospital segment dominated the market in 2021 and expected to be lucrative during the forecast period.

Get more information on this report : Request Sample Pages

 By Region

The hysterectomy device market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America accounted for a major hysterectomy device market share in 2021 and is expected to maintain its dominance during the forecast period. The presence of several major players, such as CooperCompanies, Jhonson & Jhonson and technological advancements in the region drive the growth of the market. 

In addition, surge in prevalence of uterine cancer in the region, which is expected to propel the market growth. Furthermore, the presence of well-established healthcare infrastructure and high purchasing power are expected to drive the market growth. Furthermore, acquisitions adopted by the key players in this region boost the growth of the market.  

Asia-Pacific is expected to grow at the highest rate during the hysterectomy device market forecast period. The market growth in this region is attributable to presence of pharmaceutical companies in the region as well as growth in the purchasing power of populated countries, such as China and India. Moreover, Asia-Pacific offers profitable opportunities for key players operating in the hysterectomy device market, thereby registering the fastest growth rate during the forecast period, owing to the growing infrastructure of industries, rising disposable incomes, as well as well-established presence of domestic companies in the region. In addition, the rise in contract manufacturing organizations within the region provides great opportunities for new entrants in this region.

Hysterectomy Device Market
By Region

2031
North America 
Europe
Asia-Pacific
LAMEA

North America dominated the market in 2021 and Asia-Pacific is expected to be a lucrative during the forecast period.

Get more information on this report : Request Sample Pages

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the hysterectomy devices market analysis from 2021 to 2031 to identify the prevailing hysterectomy devices market opportunities.
  • Market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders to make profit-oriented business decisions and strengthen their supplier-buyer network.
  • An in-depth analysis of the hysterectomy devices market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global hysterectomy devices market trends, key players, market segments, application areas, and market growth strategies.

Hysterectomy Device Market Report Highlights

Aspects Details
Market Size By 2031 USD 566.5 million
Growth Rate CAGR of 5.6%
Forecast period 2021 - 2031
Report Pages 389
By Surgical approach
  • Laparoscopic hysterectomy
  • Robotic assisted laparoscopic hysterectomy
  • Abdominal hysterectomy
  • Vaginal hysterectomy
By Disease type
  • Uterine Cancer
  • Fibroids
  • Chronic pelvic pain
  • Others
By End User
  • Hospitals
  • Ambulatory Surgical Centers
  • Others
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (Germany, France, UK, Italy, Spain, Rest of Europe)
  • Asia-Pacific  (Japan, China, India, Australia, South Korea, Rest of Asia-Pacific)
  • LAMEA  (Brazil, Saudi Arabia, South Africa, Rest of LAMEA)
Key Market Players KARL STORZ GmbH & Co. KG, fortimedix surgical b.v., Richard Wolf GmbH, Laborie, Inc, CONMED Corporation, Conkin surgical instruments ltd, Johnson & Johnson, Medtronic plc, B. Braun Melsungen AG, Cooper Companies, Inc.

Analyst Review

This section provides various opinions of top-level CXOs in the global hysterectomy device market. According to the insights of CXOs, increase in demand for hysterectomy market globally is expected to offer profitable opportunities for the expansion of the market. In addition, favorable government policies and schemes for women healthcare, has piqued the interest of several companies to develop advanced devices.  

CXOs further added that increase in uterine cancer in developing regions has largely contributed in the market revenue in 2021, and is expected to maintain this trend throughout the forecast period. In addition, awareness regarding use of hysterectomy device in treatment of diseases across globe, increase in demand of next generation devices in many countries significantly contributes towards the revenue generation.   

Furthermore, North America is expected to witness highest growth, in terms of revenue, owing to increase in awareness towards minimally invasive techniques and development of new advanced devices drives the market growth. However, Asia-Pacific is anticipated to witness notable growth, owing to increase in investments for healthcare drives the growth of market during the forecast period. 

 
  • CHAPTER 1: INTRODUCTION

    • 1.1. Report description

    • 1.2. Key market segments

    • 1.3. Key benefits to the stakeholders

    • 1.4. Research Methodology

      • 1.4.1. Primary research

      • 1.4.2. Secondary research

      • 1.4.3. Analyst tools and models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET OVERVIEW

    • 3.1. Market definition and scope

    • 3.2. Key findings

      • 3.2.1. Top impacting factors

      • 3.2.2. Top investment pockets

    • 3.3. Porter’s five forces analysis

      • 3.3.1. Moderate threat of substitutes

      • 3.3.2. Moderate intensity of rivalry

      • 3.3.3. High bargaining power of buyers

      • 3.3.4. High bargaining power of suppliers

      • 3.3.5. Moderate threat of new entrants

    • 3.4. Market dynamics

      • 3.4.1. Drivers

        • 3.4.1.1. Rise in prevalence of uterine cancer
        • 3.4.1.2. Increase in awareness of women’s health
        • 3.4.1.3. Technological advancements in hysterectomy devices

      • 3.4.2. Restraints

        • 3.4.2.1. Availability of alternative treatments

      • 3.4.3. Opportunities

        • 3.4.3.1. Increase in demand for the minimally invasive procedures

    • 3.5. COVID-19 Impact Analysis on the market

  • CHAPTER 4: HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE

    • 4.1. Overview

      • 4.1.1. Market size and forecast

    • 4.2. Uterine Cancer

      • 4.2.1. Key market trends, growth factors and opportunities

      • 4.2.2. Market size and forecast, by region

      • 4.2.3. Market share analysis by country

    • 4.3. Fibroids

      • 4.3.1. Key market trends, growth factors and opportunities

      • 4.3.2. Market size and forecast, by region

      • 4.3.3. Market share analysis by country

    • 4.4. Chronic pelvic pain

      • 4.4.1. Key market trends, growth factors and opportunities

      • 4.4.2. Market size and forecast, by region

      • 4.4.3. Market share analysis by country

    • 4.5. Others

      • 4.5.1. Key market trends, growth factors and opportunities

      • 4.5.2. Market size and forecast, by region

      • 4.5.3. Market share analysis by country

  • CHAPTER 5: HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH

    • 5.1. Overview

      • 5.1.1. Market size and forecast

    • 5.2. Vaginal hysterectomy

      • 5.2.1. Key market trends, growth factors and opportunities

      • 5.2.2. Market size and forecast, by region

      • 5.2.3. Market share analysis by country

    • 5.3. Laparoscopic hysterectomy

      • 5.3.1. Key market trends, growth factors and opportunities

      • 5.3.2. Market size and forecast, by region

      • 5.3.3. Market share analysis by country

    • 5.4. Robotic assisted laparoscopic hysterectomy

      • 5.4.1. Key market trends, growth factors and opportunities

      • 5.4.2. Market size and forecast, by region

      • 5.4.3. Market share analysis by country

    • 5.5. Abdominal hysterectomy

      • 5.5.1. Key market trends, growth factors and opportunities

      • 5.5.2. Market size and forecast, by region

      • 5.5.3. Market share analysis by country

  • CHAPTER 6: HYSTERECTOMY DEVICE MARKET, BY END USER

    • 6.1. Overview

      • 6.1.1. Market size and forecast

    • 6.2. Hospitals

      • 6.2.1. Key market trends, growth factors and opportunities

      • 6.2.2. Market size and forecast, by region

      • 6.2.3. Market share analysis by country

    • 6.3. Ambulatory Surgical Centers

      • 6.3.1. Key market trends, growth factors and opportunities

      • 6.3.2. Market size and forecast, by region

      • 6.3.3. Market share analysis by country

    • 6.4. Others

      • 6.4.1. Key market trends, growth factors and opportunities

      • 6.4.2. Market size and forecast, by region

      • 6.4.3. Market share analysis by country

  • CHAPTER 7: HYSTERECTOMY DEVICE MARKET, BY REGION

    • 7.1. Overview

      • 7.1.1. Market size and forecast By Region

    • 7.2. North America

      • 7.2.1. Key trends and opportunities

      • 7.2.2. Market size and forecast, by Disease type

      • 7.2.3. Market size and forecast, by Surgical approach

      • 7.2.4. Market size and forecast, by End User

      • 7.2.5. Market size and forecast, by country

        • 7.2.5.1. U.S.
          • 7.2.5.1.1. Key market trends, growth factors and opportunities
          • 7.2.5.1.2. Market size and forecast, by Disease type
          • 7.2.5.1.3. Market size and forecast, by Surgical approach
          • 7.2.5.1.4. Market size and forecast, by End User
        • 7.2.5.2. Canada
          • 7.2.5.2.1. Key market trends, growth factors and opportunities
          • 7.2.5.2.2. Market size and forecast, by Disease type
          • 7.2.5.2.3. Market size and forecast, by Surgical approach
          • 7.2.5.2.4. Market size and forecast, by End User
        • 7.2.5.3. Mexico
          • 7.2.5.3.1. Key market trends, growth factors and opportunities
          • 7.2.5.3.2. Market size and forecast, by Disease type
          • 7.2.5.3.3. Market size and forecast, by Surgical approach
          • 7.2.5.3.4. Market size and forecast, by End User
    • 7.3. Europe

      • 7.3.1. Key trends and opportunities

      • 7.3.2. Market size and forecast, by Disease type

      • 7.3.3. Market size and forecast, by Surgical approach

      • 7.3.4. Market size and forecast, by End User

      • 7.3.5. Market size and forecast, by country

        • 7.3.5.1. Germany
          • 7.3.5.1.1. Key market trends, growth factors and opportunities
          • 7.3.5.1.2. Market size and forecast, by Disease type
          • 7.3.5.1.3. Market size and forecast, by Surgical approach
          • 7.3.5.1.4. Market size and forecast, by End User
        • 7.3.5.2. France
          • 7.3.5.2.1. Key market trends, growth factors and opportunities
          • 7.3.5.2.2. Market size and forecast, by Disease type
          • 7.3.5.2.3. Market size and forecast, by Surgical approach
          • 7.3.5.2.4. Market size and forecast, by End User
        • 7.3.5.3. UK
          • 7.3.5.3.1. Key market trends, growth factors and opportunities
          • 7.3.5.3.2. Market size and forecast, by Disease type
          • 7.3.5.3.3. Market size and forecast, by Surgical approach
          • 7.3.5.3.4. Market size and forecast, by End User
        • 7.3.5.4. Italy
          • 7.3.5.4.1. Key market trends, growth factors and opportunities
          • 7.3.5.4.2. Market size and forecast, by Disease type
          • 7.3.5.4.3. Market size and forecast, by Surgical approach
          • 7.3.5.4.4. Market size and forecast, by End User
        • 7.3.5.5. Spain
          • 7.3.5.5.1. Key market trends, growth factors and opportunities
          • 7.3.5.5.2. Market size and forecast, by Disease type
          • 7.3.5.5.3. Market size and forecast, by Surgical approach
          • 7.3.5.5.4. Market size and forecast, by End User
        • 7.3.5.6. Rest of Europe
          • 7.3.5.6.1. Key market trends, growth factors and opportunities
          • 7.3.5.6.2. Market size and forecast, by Disease type
          • 7.3.5.6.3. Market size and forecast, by Surgical approach
          • 7.3.5.6.4. Market size and forecast, by End User
    • 7.4. Asia-Pacific

      • 7.4.1. Key trends and opportunities

      • 7.4.2. Market size and forecast, by Disease type

      • 7.4.3. Market size and forecast, by Surgical approach

      • 7.4.4. Market size and forecast, by End User

      • 7.4.5. Market size and forecast, by country

        • 7.4.5.1. Japan
          • 7.4.5.1.1. Key market trends, growth factors and opportunities
          • 7.4.5.1.2. Market size and forecast, by Disease type
          • 7.4.5.1.3. Market size and forecast, by Surgical approach
          • 7.4.5.1.4. Market size and forecast, by End User
        • 7.4.5.2. China
          • 7.4.5.2.1. Key market trends, growth factors and opportunities
          • 7.4.5.2.2. Market size and forecast, by Disease type
          • 7.4.5.2.3. Market size and forecast, by Surgical approach
          • 7.4.5.2.4. Market size and forecast, by End User
        • 7.4.5.3. India
          • 7.4.5.3.1. Key market trends, growth factors and opportunities
          • 7.4.5.3.2. Market size and forecast, by Disease type
          • 7.4.5.3.3. Market size and forecast, by Surgical approach
          • 7.4.5.3.4. Market size and forecast, by End User
        • 7.4.5.4. Australia
          • 7.4.5.4.1. Key market trends, growth factors and opportunities
          • 7.4.5.4.2. Market size and forecast, by Disease type
          • 7.4.5.4.3. Market size and forecast, by Surgical approach
          • 7.4.5.4.4. Market size and forecast, by End User
        • 7.4.5.5. South Korea
          • 7.4.5.5.1. Key market trends, growth factors and opportunities
          • 7.4.5.5.2. Market size and forecast, by Disease type
          • 7.4.5.5.3. Market size and forecast, by Surgical approach
          • 7.4.5.5.4. Market size and forecast, by End User
        • 7.4.5.6. Rest of Asia-Pacific
          • 7.4.5.6.1. Key market trends, growth factors and opportunities
          • 7.4.5.6.2. Market size and forecast, by Disease type
          • 7.4.5.6.3. Market size and forecast, by Surgical approach
          • 7.4.5.6.4. Market size and forecast, by End User
    • 7.5. LAMEA

      • 7.5.1. Key trends and opportunities

      • 7.5.2. Market size and forecast, by Disease type

      • 7.5.3. Market size and forecast, by Surgical approach

      • 7.5.4. Market size and forecast, by End User

      • 7.5.5. Market size and forecast, by country

        • 7.5.5.1. Brazil
          • 7.5.5.1.1. Key market trends, growth factors and opportunities
          • 7.5.5.1.2. Market size and forecast, by Disease type
          • 7.5.5.1.3. Market size and forecast, by Surgical approach
          • 7.5.5.1.4. Market size and forecast, by End User
        • 7.5.5.2. Saudi Arabia
          • 7.5.5.2.1. Key market trends, growth factors and opportunities
          • 7.5.5.2.2. Market size and forecast, by Disease type
          • 7.5.5.2.3. Market size and forecast, by Surgical approach
          • 7.5.5.2.4. Market size and forecast, by End User
        • 7.5.5.3. South Africa
          • 7.5.5.3.1. Key market trends, growth factors and opportunities
          • 7.5.5.3.2. Market size and forecast, by Disease type
          • 7.5.5.3.3. Market size and forecast, by Surgical approach
          • 7.5.5.3.4. Market size and forecast, by End User
        • 7.5.5.4. Rest of LAMEA
          • 7.5.5.4.1. Key market trends, growth factors and opportunities
          • 7.5.5.4.2. Market size and forecast, by Disease type
          • 7.5.5.4.3. Market size and forecast, by Surgical approach
          • 7.5.5.4.4. Market size and forecast, by End User
  • CHAPTER 8: COMPETITIVE LANDSCAPE

    • 8.1. Introduction

    • 8.2. Top winning strategies

    • 8.3. Product Mapping of Top 10 Player

    • 8.4. Competitive Dashboard

    • 8.5. Competitive Heatmap

    • 8.6. Top player positioning, 2021

  • CHAPTER 9: COMPANY PROFILES

    • 9.1. Conkin surgical instruments ltd

      • 9.1.1. Company overview

      • 9.1.2. Key Executives

      • 9.1.3. Company snapshot

      • 9.1.4. Operating business segments

      • 9.1.5. Product portfolio

    • 9.2. KARL STORZ GmbH & Co. KG

      • 9.2.1. Company overview

      • 9.2.2. Key Executives

      • 9.2.3. Company snapshot

      • 9.2.4. Operating business segments

      • 9.2.5. Product portfolio

    • 9.3. CONMED Corporation

      • 9.3.1. Company overview

      • 9.3.2. Key Executives

      • 9.3.3. Company snapshot

      • 9.3.4. Operating business segments

      • 9.3.5. Product portfolio

      • 9.3.6. Business performance

    • 9.4. Richard Wolf GmbH

      • 9.4.1. Company overview

      • 9.4.2. Key Executives

      • 9.4.3. Company snapshot

      • 9.4.4. Operating business segments

      • 9.4.5. Product portfolio

    • 9.5. fortimedix surgical b.v.

      • 9.5.1. Company overview

      • 9.5.2. Key Executives

      • 9.5.3. Company snapshot

      • 9.5.4. Operating business segments

      • 9.5.5. Product portfolio

    • 9.6. Johnson & Johnson

      • 9.6.1. Company overview

      • 9.6.2. Key Executives

      • 9.6.3. Company snapshot

      • 9.6.4. Operating business segments

      • 9.6.5. Product portfolio

      • 9.6.6. Business performance

    • 9.7. Laborie, Inc

      • 9.7.1. Company overview

      • 9.7.2. Key Executives

      • 9.7.3. Company snapshot

      • 9.7.4. Operating business segments

      • 9.7.5. Product portfolio

    • 9.8. Cooper Companies, Inc.

      • 9.8.1. Company overview

      • 9.8.2. Key Executives

      • 9.8.3. Company snapshot

      • 9.8.4. Operating business segments

      • 9.8.5. Product portfolio

      • 9.8.6. Business performance

      • 9.8.7. Key strategic moves and developments

    • 9.9. B. Braun Melsungen AG

      • 9.9.1. Company overview

      • 9.9.2. Key Executives

      • 9.9.3. Company snapshot

      • 9.9.4. Operating business segments

      • 9.9.5. Product portfolio

      • 9.9.6. Business performance

    • 9.10. Medtronic plc

      • 9.10.1. Company overview

      • 9.10.2. Key Executives

      • 9.10.3. Company snapshot

      • 9.10.4. Operating business segments

      • 9.10.5. Product portfolio

      • 9.10.6. Business performance

  • LIST OF TABLES

  • TABLE 01. GLOBAL HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
    TABLE 02. HYSTERECTOMY DEVICE MARKET FOR UTERINE CANCER, BY REGION, 2021-2031 ($MILLION)
    TABLE 03. HYSTERECTOMY DEVICE MARKET FOR FIBROIDS, BY REGION, 2021-2031 ($MILLION)
    TABLE 04. HYSTERECTOMY DEVICE MARKET FOR CHRONIC PELVIC PAIN, BY REGION, 2021-2031 ($MILLION)
    TABLE 05. HYSTERECTOMY DEVICE MARKET FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
    TABLE 06. GLOBAL HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH, 2021-2031 ($MILLION)
    TABLE 07. HYSTERECTOMY DEVICE MARKET FOR VAGINAL HYSTERECTOMY, BY REGION, 2021-2031 ($MILLION)
    TABLE 08. HYSTERECTOMY DEVICE MARKET FOR LAPAROSCOPIC HYSTERECTOMY, BY REGION, 2021-2031 ($MILLION)
    TABLE 09. HYSTERECTOMY DEVICE MARKET FOR ROBOTIC ASSISTED LAPAROSCOPIC HYSTERECTOMY, BY REGION, 2021-2031 ($MILLION)
    TABLE 10. HYSTERECTOMY DEVICE MARKET FOR ABDOMINAL HYSTERECTOMY, BY REGION, 2021-2031 ($MILLION)
    TABLE 11. GLOBAL HYSTERECTOMY DEVICE MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 12. HYSTERECTOMY DEVICE MARKET FOR HOSPITALS, BY REGION, 2021-2031 ($MILLION)
    TABLE 13. HYSTERECTOMY DEVICE MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2021-2031 ($MILLION)
    TABLE 14. HYSTERECTOMY DEVICE MARKET FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
    TABLE 15. HYSTERECTOMY DEVICE MARKET, BY REGION, 2021-2031 ($MILLION)
    TABLE 16. NORTH AMERICA HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
    TABLE 17. NORTH AMERICA HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH, 2021-2031 ($MILLION)
    TABLE 18. NORTH AMERICA HYSTERECTOMY DEVICE MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 19. NORTH AMERICA HYSTERECTOMY DEVICE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
    TABLE 20. U.S. HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
    TABLE 21. U.S. HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH, 2021-2031 ($MILLION)
    TABLE 22. U.S. HYSTERECTOMY DEVICE MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 23. CANADA HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
    TABLE 24. CANADA HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH, 2021-2031 ($MILLION)
    TABLE 25. CANADA HYSTERECTOMY DEVICE MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 26. MEXICO HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
    TABLE 27. MEXICO HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH, 2021-2031 ($MILLION)
    TABLE 28. MEXICO HYSTERECTOMY DEVICE MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 29. EUROPE HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
    TABLE 30. EUROPE HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH, 2021-2031 ($MILLION)
    TABLE 31. EUROPE HYSTERECTOMY DEVICE MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 32. EUROPE HYSTERECTOMY DEVICE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
    TABLE 33. GERMANY HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
    TABLE 34. GERMANY HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH, 2021-2031 ($MILLION)
    TABLE 35. GERMANY HYSTERECTOMY DEVICE MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 36. FRANCE HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
    TABLE 37. FRANCE HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH, 2021-2031 ($MILLION)
    TABLE 38. FRANCE HYSTERECTOMY DEVICE MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 39. UK HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
    TABLE 40. UK HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH, 2021-2031 ($MILLION)
    TABLE 41. UK HYSTERECTOMY DEVICE MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 42. ITALY HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
    TABLE 43. ITALY HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH, 2021-2031 ($MILLION)
    TABLE 44. ITALY HYSTERECTOMY DEVICE MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 45. SPAIN HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
    TABLE 46. SPAIN HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH, 2021-2031 ($MILLION)
    TABLE 47. SPAIN HYSTERECTOMY DEVICE MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 48. REST OF EUROPE HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
    TABLE 49. REST OF EUROPE HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH, 2021-2031 ($MILLION)
    TABLE 50. REST OF EUROPE HYSTERECTOMY DEVICE MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 51. ASIA-PACIFIC HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
    TABLE 52. ASIA-PACIFIC HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH, 2021-2031 ($MILLION)
    TABLE 53. ASIA-PACIFIC HYSTERECTOMY DEVICE MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 54. ASIA-PACIFIC HYSTERECTOMY DEVICE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
    TABLE 55. JAPAN HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
    TABLE 56. JAPAN HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH, 2021-2031 ($MILLION)
    TABLE 57. JAPAN HYSTERECTOMY DEVICE MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 58. CHINA HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
    TABLE 59. CHINA HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH, 2021-2031 ($MILLION)
    TABLE 60. CHINA HYSTERECTOMY DEVICE MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 61. INDIA HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
    TABLE 62. INDIA HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH, 2021-2031 ($MILLION)
    TABLE 63. INDIA HYSTERECTOMY DEVICE MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 64. AUSTRALIA HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
    TABLE 65. AUSTRALIA HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH, 2021-2031 ($MILLION)
    TABLE 66. AUSTRALIA HYSTERECTOMY DEVICE MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 67. SOUTH KOREA HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
    TABLE 68. SOUTH KOREA HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH, 2021-2031 ($MILLION)
    TABLE 69. SOUTH KOREA HYSTERECTOMY DEVICE MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 70. REST OF ASIA-PACIFIC HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
    TABLE 71. REST OF ASIA-PACIFIC HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH, 2021-2031 ($MILLION)
    TABLE 72. REST OF ASIA-PACIFIC HYSTERECTOMY DEVICE MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 73. LAMEA HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
    TABLE 74. LAMEA HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH, 2021-2031 ($MILLION)
    TABLE 75. LAMEA HYSTERECTOMY DEVICE MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 76. LAMEA HYSTERECTOMY DEVICE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
    TABLE 77. BRAZIL HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
    TABLE 78. BRAZIL HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH, 2021-2031 ($MILLION)
    TABLE 79. BRAZIL HYSTERECTOMY DEVICE MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 80. SAUDI ARABIA HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
    TABLE 81. SAUDI ARABIA HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH, 2021-2031 ($MILLION)
    TABLE 82. SAUDI ARABIA HYSTERECTOMY DEVICE MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 83. SOUTH AFRICA HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
    TABLE 84. SOUTH AFRICA HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH, 2021-2031 ($MILLION)
    TABLE 85. SOUTH AFRICA HYSTERECTOMY DEVICE MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 86. REST OF LAMEA HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
    TABLE 87. REST OF LAMEA HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH, 2021-2031 ($MILLION)
    TABLE 88. REST OF LAMEA HYSTERECTOMY DEVICE MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 89. CONKIN SURGICAL INSTRUMENTS LTD: KEY EXECUTIVES
    TABLE 90. CONKIN SURGICAL INSTRUMENTS LTD: COMPANY SNAPSHOT
    TABLE 91. CONKIN SURGICAL INSTRUMENTS LTD: PRODUCT SEGMENTS
    TABLE 92. CONKIN SURGICAL INSTRUMENTS LTD: PRODUCT PORTFOLIO
    TABLE 93. KARL STORZ GMBH & CO. KG: KEY EXECUTIVES
    TABLE 94. KARL STORZ GMBH & CO. KG: COMPANY SNAPSHOT
    TABLE 95. KARL STORZ GMBH & CO. KG: PRODUCT SEGMENTS
    TABLE 96. KARL STORZ GMBH & CO. KG: PRODUCT PORTFOLIO
    TABLE 97. CONMED CORPORATION: KEY EXECUTIVES
    TABLE 98. CONMED CORPORATION: COMPANY SNAPSHOT
    TABLE 99. CONMED CORPORATION: PRODUCT SEGMENTS
    TABLE 100. CONMED CORPORATION: PRODUCT PORTFOLIO
    TABLE 101. RICHARD WOLF GMBH: KEY EXECUTIVES
    TABLE 102. RICHARD WOLF GMBH: COMPANY SNAPSHOT
    TABLE 103. RICHARD WOLF GMBH: PRODUCT SEGMENTS
    TABLE 104. RICHARD WOLF GMBH: PRODUCT PORTFOLIO
    TABLE 105. FORTIMEDIX SURGICAL B.V.: KEY EXECUTIVES
    TABLE 106. FORTIMEDIX SURGICAL B.V.: COMPANY SNAPSHOT
    TABLE 107. FORTIMEDIX SURGICAL B.V.: PRODUCT SEGMENTS
    TABLE 108. FORTIMEDIX SURGICAL B.V.: PRODUCT PORTFOLIO
    TABLE 109. JOHNSON & JOHNSON: KEY EXECUTIVES
    TABLE 110. JOHNSON & JOHNSON: COMPANY SNAPSHOT
    TABLE 111. JOHNSON & JOHNSON: PRODUCT SEGMENTS
    TABLE 112. JOHNSON & JOHNSON: PRODUCT PORTFOLIO
    TABLE 113. LABORIE, INC: KEY EXECUTIVES
    TABLE 114. LABORIE, INC: COMPANY SNAPSHOT
    TABLE 115. LABORIE, INC: PRODUCT SEGMENTS
    TABLE 116. LABORIE, INC: PRODUCT PORTFOLIO
    TABLE 117. COOPER COMPANIES, INC.: KEY EXECUTIVES
    TABLE 118. COOPER COMPANIES, INC.: COMPANY SNAPSHOT
    TABLE 119. COOPER COMPANIES, INC.: PRODUCT SEGMENTS
    TABLE 120. COOPER COMPANIES, INC.: PRODUCT PORTFOLIO
    TABLE 121. COOPER COMPANIES, INC.: KEY STRATERGIES
    TABLE 122. B. BRAUN MELSUNGEN AG: KEY EXECUTIVES
    TABLE 123. B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT
    TABLE 124. B. BRAUN MELSUNGEN AG: PRODUCT SEGMENTS
    TABLE 125. B. BRAUN MELSUNGEN AG: PRODUCT PORTFOLIO
    TABLE 126. MEDTRONIC PLC: KEY EXECUTIVES
    TABLE 127. MEDTRONIC PLC: COMPANY SNAPSHOT
    TABLE 128. MEDTRONIC PLC: PRODUCT SEGMENTS
    TABLE 129. MEDTRONIC PLC: PRODUCT PORTFOLIO
  • LIST OF FIGURES

  • FIGURE 01. HYSTERECTOMY DEVICES MARKET, 2021-2031
    FIGURE 02. SEGMENTATION OF HYSTERECTOMY DEVICES MARKET, 2021-2031
    FIGURE 03. TOP INVESTMENT POCKETS IN HYSTERECTOMY DEVICES MARKET (2022-2031)
    FIGURE 04. HIGH BARGAINING POWER OF SUPPLIERS
    FIGURE 05. HIGH BARGAINING POWER OF BUYERS
    FIGURE 06. MODERATE THREAT OF SUBSTITUTES
    FIGURE 07. MODERATE THREAT OF NEW ENTRANTS
    FIGURE 08. MODERATE INTENSITY OF RIVALRY
    FIGURE 09. DRIVERS, RESTRAINTS AND OPPORTUNITIES: GLOBALHYSTERECTOMY DEVICES MARKET
    FIGURE 10. HYSTERECTOMY DEVICES MARKET, BY DISEASE TYPE, 2021(%)
    FIGURE 11. COMPARATIVE SHARE ANALYSIS OF HYSTERECTOMY DEVICES MARKET FOR UTERINE CANCER, BY COUNTRY 2021-2031(%)
    FIGURE 12. COMPARATIVE SHARE ANALYSIS OF HYSTERECTOMY DEVICES MARKET FOR FIBROIDS, BY COUNTRY 2021-2031(%)
    FIGURE 13. COMPARATIVE SHARE ANALYSIS OF HYSTERECTOMY DEVICES MARKET FOR CHRONIC PELVIC PAIN, BY COUNTRY 2021-2031(%)
    FIGURE 14. COMPARATIVE SHARE ANALYSIS OF HYSTERECTOMY DEVICES MARKET FOR OTHERS, BY COUNTRY 2021-2031(%)
    FIGURE 15. HYSTERECTOMY DEVICES MARKET, BY SURGICAL APPROACH, 2021(%)
    FIGURE 16. COMPARATIVE SHARE ANALYSIS OF HYSTERECTOMY DEVICES MARKET FOR VAGINAL HYSTERECTOMY, BY COUNTRY 2021-2031(%)
    FIGURE 17. COMPARATIVE SHARE ANALYSIS OF HYSTERECTOMY DEVICES MARKET FOR LAPAROSCOPIC HYSTERECTOMY, BY COUNTRY 2021-2031(%)
    FIGURE 18. COMPARATIVE SHARE ANALYSIS OF HYSTERECTOMY DEVICES MARKET FOR ROBOTIC ASSISTED LAPAROSCOPIC HYSTERECTOMY, BY COUNTRY 2021-2031(%)
    FIGURE 19. COMPARATIVE SHARE ANALYSIS OF HYSTERECTOMY DEVICES MARKET FOR ABDOMINAL HYSTERECTOMY, BY COUNTRY 2021-2031(%)
    FIGURE 20. HYSTERECTOMY DEVICES MARKET, BY END USER, 2021(%)
    FIGURE 21. COMPARATIVE SHARE ANALYSIS OF HYSTERECTOMY DEVICES MARKET FOR HOSPITALS, BY COUNTRY 2021-2031(%)
    FIGURE 22. COMPARATIVE SHARE ANALYSIS OF HYSTERECTOMY DEVICES MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY 2021-2031(%)
    FIGURE 23. COMPARATIVE SHARE ANALYSIS OF HYSTERECTOMY DEVICES MARKET FOR OTHERS, BY COUNTRY 2021-2031(%)
    FIGURE 24. HYSTERECTOMY DEVICES MARKET BY REGION, 2021
    FIGURE 25. U.S. HYSTERECTOMY DEVICES MARKET, 2021-2031 ($MILLION)
    FIGURE 26. CANADA HYSTERECTOMY DEVICES MARKET, 2021-2031 ($MILLION)
    FIGURE 27. MEXICO HYSTERECTOMY DEVICES MARKET, 2021-2031 ($MILLION)
    FIGURE 28. GERMANY HYSTERECTOMY DEVICES MARKET, 2021-2031 ($MILLION)
    FIGURE 29. FRANCE HYSTERECTOMY DEVICES MARKET, 2021-2031 ($MILLION)
    FIGURE 30. UK HYSTERECTOMY DEVICES MARKET, 2021-2031 ($MILLION)
    FIGURE 31. ITALY HYSTERECTOMY DEVICES MARKET, 2021-2031 ($MILLION)
    FIGURE 32. SPAIN HYSTERECTOMY DEVICES MARKET, 2021-2031 ($MILLION)
    FIGURE 33. REST OF EUROPE HYSTERECTOMY DEVICES MARKET, 2021-2031 ($MILLION)
    FIGURE 34. JAPAN HYSTERECTOMY DEVICES MARKET, 2021-2031 ($MILLION)
    FIGURE 35. CHINA HYSTERECTOMY DEVICES MARKET, 2021-2031 ($MILLION)
    FIGURE 36. INDIA HYSTERECTOMY DEVICES MARKET, 2021-2031 ($MILLION)
    FIGURE 37. AUSTRALIA HYSTERECTOMY DEVICES MARKET, 2021-2031 ($MILLION)
    FIGURE 38. SOUTH KOREA HYSTERECTOMY DEVICES MARKET, 2021-2031 ($MILLION)
    FIGURE 39. REST OF ASIA-PACIFIC HYSTERECTOMY DEVICES MARKET, 2021-2031 ($MILLION)
    FIGURE 40. BRAZIL HYSTERECTOMY DEVICES MARKET, 2021-2031 ($MILLION)
    FIGURE 41. SAUDI ARABIA HYSTERECTOMY DEVICES MARKET, 2021-2031 ($MILLION)
    FIGURE 42. SOUTH AFRICA HYSTERECTOMY DEVICES MARKET, 2021-2031 ($MILLION)
    FIGURE 43. REST OF LAMEA HYSTERECTOMY DEVICES MARKET, 2021-2031 ($MILLION)
    FIGURE 44. TOP WINNING STRATEGIES, BY YEAR
    FIGURE 45. TOP WINNING STRATEGIES, BY DEVELOPMENT
    FIGURE 46. TOP WINNING STRATEGIES, BY COMPANY
    FIGURE 47. PRODUCT MAPPING OF TOP 10 PLAYERS
    FIGURE 48. COMPETITIVE DASHBOARD
    FIGURE 49. COMPETITIVE HEATMAP: HYSTERECTOMY DEVICES MARKET
    FIGURE 50. TOP PLAYER POSITIONING, 2021
    FIGURE 51. CONMED CORPORATION: NET SALES, 2019-2021 ($MILLION)
    FIGURE 52. CONMED CORPORATION: REVENUE SHARE BY SEGMENT, 2021 (%)
    FIGURE 53. CONMED CORPORATION: REVENUE SHARE BY REGION, 2021 (%)
    FIGURE 54. JOHNSON & JOHNSON: NET REVENUE, 2019-2021 ($MILLION)
    FIGURE 55. JOHNSON & JOHNSON: REVENUE SHARE BY SEGMENT, 2021 (%)
    FIGURE 56. JOHNSON & JOHNSON: REVENUE SHARE BY REGION, 2021 (%)
    FIGURE 57. COOPER COMPANIES, INC.: NET REVENUE, 2019-2021 ($MILLION)
    FIGURE 58. COOPER COMPANIES, INC.: REVENUE SHARE BY SEGMENT, 2021 (%)
    FIGURE 59. B. BRAUN MELSUNGEN AG: NET SALES, 2019-2021 ($MILLION)
    FIGURE 60. B. BRAUN MELSUNGEN AG: REVENUE SHARE BY REGION, 2021 (%)
    FIGURE 61. B. BRAUN MELSUNGEN AG: REVENUE SHARE BY SEGMENT, 2021 (%)
    FIGURE 62. MEDTRONIC PLC: NET SALES, 2020-2022 ($MILLION)
    FIGURE 63. MEDTRONIC PLC: REVENUE SHARE BY SEGMENT, 2022 (%)
    FIGURE 64. MEDTRONIC PLC: REVENUE SHARE BY REGION, 2022 (%)

 
 

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com
 
FREQUENTLY ASKED QUESTIONS?

A. Abdominal hysterectomy is the leading application of hysterectomy device market.

A. Rise in prevalence of uterine cancer, rise in awareness about women's health, and technological advancements are the upcoming trends in hysterectomy device market.

A. North America is the largest regional market for hysterectomy device.

A. Cooper Companies, B. Braun Melsunge AG, Jhonson & Jhonson, and Medtronic corporation are the top companies to hold the market share in Hysterectomy Device.

A. The total market value of hysterectomy device market is $328.09 million in 2021.

A. The market value of hysterectomy device market in 2031 is $566.5 million.

A. The forecast period for hysterectomy device market is 2022 to 2031.

A. Chronic pelvic pain is the most influencing segment in hysterectomy device market which is attributed to rise in demand for hysterectomy procedure for the treatment of the chronic pelvic pain

A. Asia-Pacific has the highest growth rate in the market with highest CAGR of 6.6%. This is due to rise in prevalence of uterine cancer cases in developing regions and increase in awareness about women's health.

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Request Sample
RELATED TAGS

Purchase Full Report of
Hysterectomy Device Market

Start reading instantly.
This Report and over 67,404+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,570
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
    (Aug 2024 - Aug 2025)
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Aug 2024 - Aug 2025)
  • Single User
  • $5,730
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Aug 2024 - Aug 2025)
  • Five Users
  • $6,450
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Aug 2024 - Aug 2025)
  • Enterprise
    License/PDF

  • $9,600
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Aug 2024 - Aug 2025)
  • Library
    Membership

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers